Denali Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Denali Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Denali Therapeutics Inc
Rating: 1.33025
Author: Trendlyne DVM scores

about

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

14.52 -0.83 (-5.41%)

56.44% Fall from 52W High

1.7M

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.0 / 100

Technically Neutral

44.2 / 100

1Yr Price target upside is 174%

15 analysts

Denali Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Denali Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant ...

56.44% Fall from 52W High

SWOT Analysis

Denali Therapeutics Inc Live Price Chart